SRC Activation Drives Acquired Pemetrexed Resistance in Non-Small Cell Lung Cancer and Is Targetable by Dasatinib.
Overview & Synopsis
Open access biomedical research article published in Thorac Cancer.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | SRC Activation Drives Acquired Pemetrexed Resistance in Non-Small Cell Lung Cancer and Is Targetable by Dasatinib. |
|---|---|
| Author / Organization | Seo J, Kim KJ, Kim SH, Sung JH, Hwang SH, Park W, Kang M, Jung EH, Kim SA, Suh KJ, Lee JY, Kim JW, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM, Kwon JH, Lee JS |
| Subject & Discipline | Thorac Cancer |
| Categories | Medicine & Health |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-33632 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |